Medicinova, Inc.

MNOV

Medicinnova, Inc. is a biotechnology company focused on developing novel therapeutics for rare and serious diseases. The company's research primarily targets conditions with limited treatment options, leveraging its expertise in drug discovery and development to bring innovative solutions to unmet medical needs.

$1.51 -0.05 (-2.88%)

Company News

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

GlobeNewswire Inc. • Medicinova, Inc. • December 8, 2025

MediciNova completed randomization of 234 patients in its COMBAT-ALS clinical trial for MN-166, a potential treatment for Amyotrophic Lateral Sclerosis. The company anticipates top-line data by end of 2026 and remains hopeful about the drug's therapeutic potential.

Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket

Benzinga • Avi Kapoor • March 27, 2024

Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Destiny Tech100 Inc (NASDAQ: DX...

FRGE PRGS MIRA GME ABTS STKS

3 Top Biotech Stocks to Buy Right Now

The Motley Fool • [email protected] (Jim Halley) • June 26, 2021

These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors.

AVXL TARS